Savara (SVRA) Received H.C. Wainwright’s Coverage; Kensico Capital Management Lowered Constellation Brands (STZ) Position

May 25, 2018 - By Vivian Park

In a analysts note sent to investors and clients on 25 May, stock analysts at H.C. Wainwright initiated coverage on shares of Savara Inc (SVRA). The firm set a “Buy” rating with $22.0000, giving 157.31% to target.

Kensico Capital Management Corp decreased Constellation Brands Inc (STZ) stake by 23.6% reported in 2017Q4 SEC filing. Kensico Capital Management Corp sold 1.35M shares as Constellation Brands Inc (STZ)’s stock declined 2.39%. The Kensico Capital Management Corp holds 4.37 million shares with $998.85 million value, down from 5.72M last quarter. Constellation Brands Inc now has $41.58 billion valuation. The stock increased 0.18% or $0.38 during the last trading session, reaching $216.96. About 1.24M shares traded. Constellation Brands, Inc. (NYSE:STZ) has risen 33.47% since May 25, 2017 and is uptrending. It has outperformed by 21.92% the S&P500.

More important recent Constellation Brands, Inc. (NYSE:STZ) news were published by: Globenewswire.com which released: “Constellation Brands to Present at the RBC 2018 Consumer and Retail Conference, May 30, 2018” on May 24, 2018, also Investorplace.com published article titled: “20 Stocks Hedge Fund Managers Are Buying In Bulk”, Seekingalpha.com published: “Tracking Dan Loeb’s Third Point Portfolio – Q1 2018 Update” on May 22, 2018. More interesting news about Constellation Brands, Inc. (NYSE:STZ) was released by: Profitconfidential.com and their article: “Marijuana Stocks: 3 Stocks with the Next Best Takeover Potential for Pot Giants” with publication date: May 24, 2018.

Since January 30, 2018, it had 0 buys, and 4 insider sales for $6.69 million activity. FROMBERG BARRY A had sold 3,000 shares worth $687,672 on Monday, April 2. $1.47 million worth of Constellation Brands, Inc. (NYSE:STZ) was sold by LOCKE JAMES A III on Tuesday, April 17. Klein David Eric also sold $4.09 million worth of Constellation Brands, Inc. (NYSE:STZ) shares.

Analysts await Constellation Brands, Inc. (NYSE:STZ) to report earnings on July, 5. They expect $2.48 earnings per share, up 5.98% or $0.14 from last year’s $2.34 per share. STZ’s profit will be $475.29 million for 21.87 P/E if the $2.48 EPS becomes a reality. After $1.90 actual earnings per share reported by Constellation Brands, Inc. for the previous quarter, Wall Street now forecasts 30.53% EPS growth.

Investors sentiment increased to 1.24 in 2017 Q4. Its up 0.10, from 1.14 in 2017Q3. It increased, as 43 investors sold STZ shares while 243 reduced holdings. 97 funds opened positions while 257 raised stakes. 140.30 million shares or 2.61% less from 144.05 million shares in 2017Q3 were reported. Park Presidio Cap Ltd Limited Liability Company, California-based fund reported 260,000 shares. Parallax Volatility Advisers Lp invested in 4,040 shares or 0% of the stock. Old Second Natl Bank Of Aurora holds 1.29% in Constellation Brands, Inc. (NYSE:STZ) or 14,276 shares. Cornerstone Advsrs reported 11,000 shares. Patten Patten Inc Tn holds 1.73% of its portfolio in Constellation Brands, Inc. (NYSE:STZ) for 75,567 shares. Covington Capital Management owns 600 shares. Senator Lp holds 3.43% of its portfolio in Constellation Brands, Inc. (NYSE:STZ) for 1.40 million shares. State Of Tennessee Treasury Department owns 0.35% invested in Constellation Brands, Inc. (NYSE:STZ) for 338,742 shares. Tdam Usa holds 1,417 shares. Eaton Vance holds 541,272 shares or 0.3% of its portfolio. Van Hulzen Asset Mngmt Lc has invested 0.21% in Constellation Brands, Inc. (NYSE:STZ). D E Shaw Communications, a New York-based fund reported 212,788 shares. Graham Cap Mngmt Limited Partnership owns 4,550 shares for 0.03% of their portfolio. 234,945 were reported by State Board Of Administration Of Florida Retirement. Burns J W And Communication New York reported 0.46% in Constellation Brands, Inc. (NYSE:STZ).

Among 23 analysts covering Constellation Brands (NYSE:STZ), 15 have Buy rating, 0 Sell and 8 Hold. Therefore 65% are positive. Constellation Brands had 83 analyst reports since August 27, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Friday, March 23 by Deutsche Bank. UBS maintained Constellation Brands, Inc. (NYSE:STZ) rating on Friday, April 7. UBS has “Neutral” rating and $176.0 target. The stock of Constellation Brands, Inc. (NYSE:STZ) has “Buy” rating given on Monday, June 26 by Morgan Stanley. The rating was downgraded by Stifel Nicolaus on Tuesday, April 3 to “Hold”. On Thursday, March 29 the stock rating was maintained by Cowen & Co with “Buy”. The stock of Constellation Brands, Inc. (NYSE:STZ) has “Hold” rating given on Wednesday, February 1 by HSBC. Argus Research maintained Constellation Brands, Inc. (NYSE:STZ) rating on Monday, January 11. Argus Research has “Buy” rating and $172 target. The stock has “Buy” rating by Argus Research on Thursday, October 8. Morgan Stanley maintained the stock with “Buy” rating in Monday, July 10 report. RBC Capital Markets maintained the stock with “Buy” rating in Thursday, September 14 report.

The stock decreased 0.12% or $0.01 during the last trading session, reaching $8.55. About 76,827 shares traded. Savara Inc. (SVRA) has risen 12.18% since May 25, 2017 and is uptrending. It has outperformed by 0.63% the S&P500.

More notable recent Savara Inc. (NASDAQ:SVRA) news were published by: Streetinsider.com which released: “UPDATE: HC Wainwright Starts Savara (SVRA) at Buy” on May 25, 2018, also Globenewswire.com with their article: “New Research: Key Drivers of Growth for PCM, WGL, Savara, ConforMIS, Sandy Spring, and West Pharmaceutical …” published on May 23, 2018, Seekingalpha.com published: “Savara’s (SVRA) CEO Rob Neville on Q1 2018 Results – Earnings Call Transcript” on May 10, 2018. More interesting news about Savara Inc. (NASDAQ:SVRA) were released by: Nasdaq.com and their article: “Savara Reports First Quarter 2018 Financial Results and Provides Business Update” published on May 09, 2018 as well as Nasdaq.com‘s news article titled: “Savara to Present at Bank of America Merrill Lynch 2018 Healthcare Conference on May 15th” with publication date: May 03, 2018.

Analysts await Savara Inc. (NASDAQ:SVRA) to report earnings on August, 8. They expect $-0.33 EPS, up 63.33% or $0.57 from last year’s $-0.9 per share. After $-0.32 actual EPS reported by Savara Inc. for the previous quarter, Wall Street now forecasts 3.13% negative EPS growth.

Savara Inc., a clinical-stage specialty pharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. The company has market cap of $261.69 million. The Company’s product pipeline comprises AeroVanc, a Phase III ready inhaled formulation of vancomycin for the treatment of persistent methicillin-resistant staphylococcus aureus and lung infection in cystic fibrosis patients; Molgradex, a Phase II/III stage inhaled granulocyte-macrophage colony-stimulating factor for the treatment of autoimmune pulmonary alveolar proteinosis; and Aironite, an inhaled nebulized sodium nitrite solution to treat heart failure with preserved ejection fraction. It currently has negative earnings.

Among 4 analysts covering Savara (SVRA), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Savara has $32.0 highest and $18.0 lowest target. $24.25’s average target is 183.63% above currents $8.55 stock price. Savara had 9 analyst reports since June 7, 2017 according to SRatingsIntel. The firm has “Buy” rating by Jefferies given on Thursday, March 15. The rating was maintained by Roth Capital on Monday, October 30 with “Buy”. The firm has “Buy” rating by Canaccord Genuity given on Tuesday, September 26. Canaccord Genuity maintained the stock with “Buy” rating in Monday, October 30 report. Roth Capital maintained Savara Inc. (NASDAQ:SVRA) on Wednesday, September 27 with “Buy” rating. Canaccord Genuity maintained Savara Inc. (NASDAQ:SVRA) on Monday, April 9 with “Buy” rating.

Constellation Brands, Inc. (NYSE:STZ) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>